PYX-201, an auristatin-carrying ADC targeting the extra-domain B splice variant of fibronectin (EDB + FN, an extracellular matrix protein abundantly expressed in the tumor microenvironment), is currently being evaluated in a phase I monotherapy trial (NCT06795412) and a phase I/II combination trial with pembrolizumab (NCT05720117) in patients with advanced solid tumors 242
[DOI] [PubMed] [PMC] Akakpo JY, Ramachandran A, Curry SC, Rumack BH, Jaeschke H
These formulations bring you the power of glutathione with proven ingredients for a healthy, glowing skin journey
GSH also detoxifies electrophilic xenobiotics compounds (chemical carcinogens, environmental pollutants, drugs, etc.) and their metabolites to GSH adduct (GS-X) in the direct catalysis of glutathione-S-transferase (GST, primary approach) [32]